New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 23, 2014
16:01 EDTFB, AMZN, HPQ, TSLA, SINA, AAPL, TWTR, GILDOptions Update; May 23, 2014
iPath S&P 500 VIX Short-Term Futures down 29c to 34.95 Option volume leaders: AAPL HPQ GILD SINA AMZN TWTR TSLA FB according to Track Data.
News For AAPL;HPQ;GILD;SINA;AMZN;TWTR;TSLA;FB From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | all recent news | >>
July 15, 2015
13:52 EDTTWTRSoftbank COO says would be interested in Twitter 'at right price,' Fortune says
Subscribe for More Information
13:37 EDTAMZNAmazon's 'Prime Day' peak order rates surpass 2014's Black Friday, CNBC says
Subscribe for More Information
13:29 EDTAMZNAmazon users complain about Prime Day troubles, CNBC reports
Amazon's Prime Day, a day full of savings for customers of Amazon's "Prime" status, has received negative feedback from users, who complained that the deals didn't match the hype, CNBC reports. High profile items such as Amazon's Fire TV Stick lasted only a couple of hours before the savings were fully claimed, and the waitlist for the device was filled soon after, leading to many frustrated customers complaining that they were intentionally misled, the report says. The company said it was part of a bigger plan to "stagger the deals to make sure the fun will last through tonight," Bloomberg reports, citing a company spokeswoman. Amazon experience problems dealing with its surge of customers heading to the site in the middle of the day, according to data from Catchpoint Systems. Reference Link
12:38 EDTAAPLGundlach says out of Apple position
Subscribe for More Information
12:18 EDTTWTRTwitter rolls out data dashboard for all users
In a blog post the company said: "Today, we’re continuing to roll out to all users the Twitter data dashboard — a new tool to help you monitor and manage your account....Now, your Twitter data dashboard — which you can access from the settings menu on twitter.com — shows your account activation details, the devices that have accessed your account and your recent login history. With this information, you can quickly review your account activity and verify that everything looks the way it should." Reference Link
11:01 EDTAAPLApple introduces new iPod touch, unveils new colors for iPod models
Subscribe for More Information
10:01 EDTSINAOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
09:53 EDTAAPLHSBC UK says Apple Pay support coming within 2 weeks, Apple Insider says
HSBC UK (HSBC) said that Apple Pay (AAPL) support is in its final testing and availability will be coming within two weeks, reports Apple Insider. An HSBC spokesperson said, "We are excited to be one of a small number of Apple Pay launch partners. We have been working closely with Apple and are now properly reviewing and testing our systems before launching in two weeks." Reference Link
09:32 EDTFB, AAPLActive equity options trading on open
Active equity options trading on open: AAPL FB BAC RCPT MU YUM NFLX CELG
09:23 EDTSINAOn The Fly: Pre-market Movers
UP AFTER EARNINGS: Bank of America (BAC), up 2.9%... CSX (CSX), up 2.6%. ALSO HIGHER: Hertz (HTZ), up 3.9% after being upgraded to Buy from Hold at Deutsche Bank. NOTABLE: Receptos (RCPT), up 10.5% following deal to be acquired by Celgene (CELG)... Celgene is up 7.9% after announcing acquisition of Receptos... UP AFTER RECEPTOS/CELGENE DEAL: ZIOPHARM Oncology (ZIOP), up 1.7%... Arena Pharmaceuticals (ARNA), up 6.5%. DOWN AFTER EARNINGS: Delta Air Lines (DAL), down 2.4%. ALSO LOWER: Mead Johnson (MJN), down 4.8% after reducing fiscal 2015 EPS guidance... Columbia Pipeline Partners (CPPL), down 5.6% after 4.64M share Block Trade priced at $24.15... SINA (SINA), down 2.7% after being downgraded to Hold from Buy at Deutsche Bank... MacroGenics (MGNX), down 2.8% after 3.25M share Secondary priced at $37.00.
09:18 EDTFBAdobe's Flash disabled by Google due to security worries, WSJ says
Just days after Facebook's (FB) top security executive called on Adobe (ADBE) to discontinue its Flash animation player, Google’s (GOOG) Chrome and Mozilla’s Firefox browsers blocked old versions of the software on Tuesday after reports that hackers were using a security flaw to infiltrate computers, reported The Wall Street Journal's "Digits" blog. Firefox and Chrome will allow Flash to run again if it is updated with the patch Adobe released Tuesday morning, the report noted. Reference Link
09:08 EDTAMZNAmazo Studios announces Spike Lee's Chi-Raq as Amazon original movie
Subscribe for More Information
08:33 EDTFBFacebook target raised to $110 at Morgan Stanley on mobile ad strength
Morgan Stanley raised 2015 and 2016 revenue estimates for Facebook and increased its price target on the shares to $110 due to scale and improving products. The firm's mobile ad checks indicate Facebook is still the mobile industry leader, has low pricing and high ad ROI, and continues to pull in a larger share of ad budgets and ad dollars per MAU. Morgan Stanley has an Overweight rating on shares of the social network owner, which closed yesterday at $89.68.
08:27 EDTFBAdobe says Google display ad strategy underperforms Facebook in Q2
In its "Digital Advertising & Social Intelligence Report" for Q2, Adobe (ADBE) wrote that Facebook's (FB) display ad changes doubled its click-through-rates, or CTRs, year-over-year in the quarter, while Google's (GOOG) display targeting changes reduced its number of ads seen by 22% compared to the prior year and its CTRs were up "only" 24% compared to the same period of last year. The report also contends that the "Mobilegeddon" fears regarding Google's changes to favor mobile friendly sites came true, noting that sites with low mobile engagement saw up to a 10% decrease in organic traffic after the changes were made by the search giant. Reference Link
07:58 EDTGILDAnalysts break down impact of $7.2B Receptos buyout
After Celgene (CELG) announced last night that the company has agreed to acquire Receptos (RCPT) for $232 per share in cash, or a total of about $7.2B net of cash acquired, research firms have chimed in with their opinions on how the proposed deal may impact others in the biotech space. Receptos key asset is Ozanimod, which is being studied in Phase III trials for relapsing multiple sclerosis and ulcerative colitis. DERIVATIVE CALLS: Piper Jaffray analyst Edward Tenthoff told investors that he views Celgene's deal for Receptos as good for Arena Pharmaceuticals (ARNA). The analyst notes that Arena's APD334 is already showing dose-dependent decreases in circulating lymphocyte counts and that the company will initiate Phase II studies in ulcerative colitis and Crohn's disease this year. Tenthoff reiterates an Overweight rating and $7.50 price target on Arena, which has a market capitalization around $1B and closed yesterday up 8c to $4.47. In its own note to investors this morning, Nomura said Celgene's deal could put downward pressure on Biogen's (BIIB) long-term multiple sclerosis estimates. Nomura's M. Ian Somaiya contended that one-year Phase II efficacy data for Ozanimod looked as good as Novartis’s (NVS) Gilenya and Biogen's Tecfidera’s Phase III at year 2. Somaiya also wondered if rival Gilead (GILD) could be "looking for something bigger" than Receptos for its own deal, telling investors that the firm views Incyte (INCY) as Gilead's most likely takeout target. Incyte's shares closed up $4.46 at $117.46 yesterday, giving the company a market cap of about $20B. RIVAL BID?: Wedbush analyst Liana Moussatos believes another bidder may seek to acquire Receptos, noting that she previously estimated Receptos could be valued at $348 per share, or about $10.9B, in a buyout. Moussatos noted that Celgene said it expects annual peak sales for Ozanimod to reach about $4B-$6B for RMS and UC, making its acquisition price of $7.2BN only a bit more than about 1X peak sales without accounting for other possible indications or the rest of its pipeline. Moussatos told investors she sees "plenty" of potential upside to justify a rival bidder stepping in and reiterated the firm's Outperform rating on Receptos shares. PRICE ACTION: In pre-market trading, Receptos rose 10% to $228.61 while Gilead gained 1.4% to about $119 per share.
06:49 EDTSINASINA downgraded to Hold from Buy at Deutsche Bank
Subscribe for More Information
06:39 EDTAAPLApple to release new iPod touch, 9to5Mac reports
Subscribe for More Information
06:33 EDTAAPLApple 'in touch' with Iranian distributors to sell products there, WSJ reports
Subscribe for More Information
06:32 EDTTSLATesla buys 2,000 extra acres for Nevada factory, WSJ reports
Tesla has almost tripled its land holdings in Nevada recently, having bought nearly 2,000 additional acres near Reno as it works on a factory intended to build batteries for electric cars and stationary backup batteries, the Wall Street Journal reports. Tesla originally bought 1,000 acres last year, though that agreement including options to purchase additional land, the report says. Reference Link
06:29 EDTTWTREvan Williams would leave Twitter board if 3 former CEOs not preferred, WSJ says
Subscribe for More Information
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use